Cryoport Balance Sheet Health
Financial Health criteria checks 4/6
Cryoport has a total shareholder equity of $400.1M and total debt of $371.3M, which brings its debt-to-equity ratio to 92.8%. Its total assets and total liabilities are $852.3M and $452.2M respectively.
Key information
92.8%
Debt to equity ratio
US$371.28m
Debt
Interest coverage ratio | n/a |
Cash | US$427.14m |
Equity | US$400.10m |
Total liabilities | US$452.25m |
Total assets | US$852.34m |
Recent financial health updates
Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Jul 22Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Is Cryoport (NASDAQ:CYRX) Using Too Much Debt?
Oct 17Recent updates
The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More
Aug 09Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Jul 22Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch
Jun 25Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk
Apr 15Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 15Cryoport Tanks On Chilling Results And Bad Decisions
Mar 14Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Mar 10Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)
Jan 15Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?
Oct 06Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term
Jul 23Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity
Jul 12Is Cryoport (NASDAQ:CYRX) A Risky Investment?
Jun 13Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 06Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially
Nov 07Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?
Sep 23Cryoport: A Rare Investing Opportunity
Sep 22Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services
Sep 08Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
Jul 30Cryoport: To Resume Aggressive Growth
May 11Cryoport: An Industry Leader Basking In Industry Tailwinds
Apr 15Cryoport: Risky Investment With Upside Potential
Apr 01Cryoport: More Growth Going Into New Year 2022
Dec 29Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 49% Discount?
Dec 05What Is Cryoport, Inc.'s (NASDAQ:CYRX) Share Price Doing?
Nov 09Is Cryoport (NASDAQ:CYRX) Using Too Much Debt?
Oct 17Financial Position Analysis
Short Term Liabilities: CYRX's short term assets ($502.0M) exceed its short term liabilities ($59.9M).
Long Term Liabilities: CYRX's short term assets ($502.0M) exceed its long term liabilities ($392.4M).
Debt to Equity History and Analysis
Debt Level: CYRX has more cash than its total debt.
Reducing Debt: CYRX's debt to equity ratio has increased from 13.5% to 92.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYRX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CYRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.